Send Inquiry

Request To Call Back

Celdach 50 mg Injection

Name: Celdach 50 mg Injection
Brand: SIDMEX INOVIA PRIVATE LIMITED
Price: 517.0 INR
Availability: InStock

Price 517.0 INR/ Piece

Get a Price/Quote

MOQ : 390 Pieces

Celdach 50 mg Injection Specification

Packaging Type
Vial

Indication
Treatment of various cancers, including Wilms tumor, rhabdomyosarcoma, Ewings sarcoma, and gestational trophoblastic neoplasia

Brand Name
Celdach

Life Span
Refer to expiry date on packaging

Salt Composition
Dactinomycin

Origin of Medicine
INDIA

Dosage Form
Lyophilized powder for reconstitution

Pacakaging (Quantity Per Box)
1 vial per box

Drug Type
Prescription only, cytotoxic drug

Ingredients
Dactinomycin (Actinomycin D) 50 mg

Physical Form
Liquid

Function
Antineoplastic agent

Recommended For
DOCTOR

Dosage
As prescribed by the physician, based on body surface area and medical condition

Dosage Guidelines
Administer intravenously under strict medical supervision

Suitable For
Cancer patients

Quantity
390 Pieces

Storage Instructions
Store below 25C. Protect from light. Do not freeze.

Warning
Cytotoxic. For use only by qualified professionals. Handle with appropriate safety precautions.

Reconstitution Requirements
Reconstitute with appropriate diluent as directed before IV infusion

Prescription Status
Schedule H Prescription Drug (to be sold by retail on the prescription of a registered medical practitioner only)

Therapeutic Class
Antineoplastic / Chemotherapy

Caution
Not for intrathecal use. Fatal reactions have occurred with incorrect administration route.

Molecular Formula
C62H86N12O16

Side Effects
Potential side effects include gastrointestinal disturbances, bone marrow suppression, and increased risk of infection

Administration Route
Intravenous (IV) use only

Contraindications
Contraindicated in patients with known hypersensitivity to Dactinomycin and in those with existing severe bone marrow depression

Celdach 50 mg Injection Trade Information

Minimum Order Quantity
390 Pieces

Supply Ability
1000 Pieces Per Month

Delivery Time
1 Week

About Celdach 50 mg Injection

Celdach 50 mg Injection is an effective treatment option for individuals battling colon and rectal cancer, as it specifically targets and inhibits the proliferation of cancerous cells in these areas. This medication works by disrupting the pathways that allow cancer cells to grow and multiply, thereby helping to slow disease progression and improve patient outcomes. While Celdach offers significant benefits in managing cancer, it is important for patients to be aware of potential side effects, including nausea, fatigue, and changes in blood counts, which should be monitored closely by healthcare professionals. Additionally, individuals with pre-existing liver or kidney conditions, as well as those who are pregnant or breastfeeding, should consult their physician before starting this treatment to ensure it is appropriate for their situation. Regular follow-up appointments are essential for assessing the efficacy of the treatment and making necessary adjustments. Celdach 50 mg Injection is typically administered under medical supervision, ensuring that patients receive the highest standard of care throughout their treatment journey. If you or a loved one are facing a diagnosis of colon or rectal cancer, discussing the potential benefits and risks of Celdach with your oncologist could be a vital step towards effective management of the disease.

Precise Cancer Treatment Solution

Celdach 50 mg Injection is a carefully formulated chemotherapy drug that targets various types of cancers. Specifically designed for intravenous administration by medical professionals, it helps inhibit the growth and spread of malignant cells. Its precise use in treating conditions like Wilms tumor, Ewing's sarcoma, and others, makes it a trusted choice in oncology.

Ensuring Safe Administration

Administering Celdach requires strict adherence to safety protocols, owing to its cytotoxic nature. The injection must be reconstituted properly with the advised diluent before intravenous use. Only qualified healthcare professionals should handle and administer this medication to ensure the safety of both the patient and handler.

Special Storage and Handling

To preserve the efficacy of Celdach 50 mg Injection, storage below 25C and protection from light is mandatory. Avoid freezing the vial. The product's cytotoxic profile necessitates special care during preparation, administration, and disposal.

FAQ's of Celdach 50 mg Injection:

Q: How should Celdach 50 mg Injection be administered?

A: Celdach 50 mg Injection must be administered intravenously after proper reconstitution with the prescribed diluent, strictly under medical supervision by qualified healthcare professionals.

Q: What is the process for preparing Celdach 50 mg Injection for use?

A: To prepare Celdach for infusion, reconstitute the lyophilized powder with the recommended diluent as directed in product guidelines, ensuring all handling and mixing occurs with appropriate cytotoxic precautions.

Q: When is Celdach 50 mg Injection indicated for use?

A: Celdach is prescribed for the treatment of cancers such as Wilms tumor, rhabdomyosarcoma, Ewing's sarcoma, and gestational trophoblastic neoplasia, as determined by an oncologist or relevant specialist.

Q: Where should Celdach 50 mg Injection be stored?

A: Store Celdach below 25C, away from light, and never freeze it. It should remain securely stored in a suitable medical facility until use.

Q: What are the potential side effects of Celdach 50 mg Injection?

A: Potential side effects include gastrointestinal disturbances, bone marrow suppression, and increased susceptibility to infections. Immediate medical supervision is essential to monitor and manage any adverse reactions.

Q: Who should not use Celdach 50 mg Injection?

A: Celdach should not be administered to individuals with known hypersensitivity to dactinomycin or those suffering from severe bone marrow depression. It is contraindicated in these populations.

Q: What is the benefit of using Celdach 50 mg Injection in cancer treatment?

A: Celdach targets and inhibits the growth of cancer cells, offering an effective treatment modality for specific cancers. Its targeted action under professional supervision helps improve patient outcomes in oncology.